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Summary. This study compared the effects of leucine and glutamine
on the mTOR pathway, on protein synthesis and on muscle-specific
gene expression in myogenic C2C12 cells. Leucine increased the phos-
phorylation state of mTOR, on both Ser2448 and Ser2481, and its
downstream effectors, p70S6k, S6 and 4E-BP1. By contrast, glutamine
decreased the phosphorylation state of mTOR on Ser2448, p70S6k and
4E-BP1, but did not modify the phosphorylation state of mTOR on
Ser2481 and S6. Whilst the phosphorylation state of the mTOR path-
way is usually related to protein synthesis, the incorporation of labelled
methionine=cysteine was only transiently modified by leucine and was
unaltered by glutamine. However, these two amino acids affected the
mRNA levels of desmin, myogenin and myosin heavy chain in a time-
dependant manner. In conclusion, leucine and glutamine have opposite
effects on the mTOR pathway. Moreover, they induce modification of
muscle-specific gene expression, unrelated to their effects on the
mTOR=p70S6k pathway.
Keywords: Amino acids – p70S6k – 4E-BP1 – protein synthesis – gene
expression
1. Introduction
Amino acids are the building blocks for protein synthesis
which they are also able to regulate by modulating signal-
ling pathways. In many cell types, amino acids increase
the phosphorylation state of p70 ribosomal S6 kinase
(p70S6k) and eukaryotic initiation factor 4E-binding pro-
tein 1 (4E-BP1), two proteins downstream of the mamma-
lian target of rapamycin (mTOR) and playing a key role in
the control of protein synthesis initiation (for review see
Proud, 2002; Jefferson and Kimball, 2003; Deldicque
et al., 2005). The way by which amino acids stimulate
p70S6k and 4E-BP1 is not fully understood but clearly
involves the mTOR pathway, which senses nutrients and
regulates transcription, translation and protein degrada-
tion (Rohde et al., 2001).
Leucine, a branched chain amino acid, seems to be a
particularly effective anabolic agent. It is known to acti-
vate p70S6k in hepatocytes (Krause et al., 2002), pancre-
atic beta cells (Xu et al., 1998) and adipocytes (Fox et al.,
1998). Leucine also increases the phosphorylation state of
p70S6k in proliferating L6 (Kimball et al., 1999) and
C2C12 myogenic cells (Du et al., 2007). Recently, Nakajo
et al. (2005) have studied the effect of 14 amino acids on
p70S6k activity in intestinal epithelial cells. In this cell
type, both leucine and arginine activated p70S6k whereas
glutamine did not modify its activity. By contrast, gluta-
mine reversed the activation of p70S6k induced by leucine
and arginine when it was combined with one of these two
amino acids. Unlike in hepatocytes (Krause et al., 2002),
in which glutamine is able to activate p70S6k alone or in
combination with leucine, glutamine negatively regulated
the mTOR pathway in intestinal epithelial cells (Nakajo
et al., 2005).
In addition to controlling protein translation and more
particularly p70S6k and 4E-BP1, evidence that amino acids
may also induce or repress gene transcription is growing.
Amino acid deprivation upregulates genes involved in nu-
trient catabolism and energy production and downregulates
genes participating in lipid and nucleotide synthesis and
in protein synthesis, turnover and folding (Peng et al.,
2002). In myogenic cells, amino acid sufficiency is required
to activate IGF-II transcription via the mTOR pathway lead-
ing to enhanced differentiation (Erbay et al., 2003). Recent-
ly, the mTOR pathway has been found to be critical in the
cardiac transcriptional response to glutamine. The addition
of glutamine to cultured rat cardiomyocytes increased abun-
dance of the mRNAs encoding contractile proteins and met-
abolic enzymes through the protein kinase A and mTOR
cascades (Xia et al., 2003).
Since the effect of amino acids on the phosphorylation
state of p70S6k has been reported in several cell types, but
only a few papers present data supporting a stimulation
of protein synthesis (Kimball et al., 1999; Mordier et al.,
2000; Du et al., 2007), the purpose of the present work
was to analyze the effect of leucine and glutamine on
several proteins constituting or regulating the mTOR
signalling pathway and their ability, separately or in
combination, to modify the protein synthesis rate in dif-
ferentiating myogenic C2C12 cells. Since labelled methio-
nine=cysteine incorporation was only affected to a minor
extent by leucine, the second purpose of this work was to
test if the changes observed in p70S6k phosphorylation
could alter gene expression.
2. Materials and methods
2.1 Cell culture
C2C12 murine skeletal muscle myoblasts (ATCC) were seeded in Petri
culture dishes. They were grown in DMEM (Dulbecco’s modified Eagle’s
medium, Life Technologies) supplemented with 10% fetal bovine serum,
penicillin=streptomycin (5000 U=5000mg=ml) and 100mM non-essential
amino acids. When cells were 70% confluent, the proliferation medium
was replaced by a differentiation medium containing 1% horse serum. After
48 h of differentiation, cells were incubated for 1 h with serum-free DMEM
lacking leucine and glutamine (Life Technologies). Leucine (5 mM), gluta-
mine (5 mM) or both (5 mM each) (Sigma) were then added to the plates.
Phosphorylation states and protein synthesis. Cells were lysed after
30 min, 3 h and 24 h, in a buffer (pH 7.0) containing 20 mM Tris, 270 mM
sucrose, 5 mM EGTA, 1mM EDTA, 1% Triton X-100, 1 mM sodium ortho-
vanadate, 50 mM sodium b-glycerophosphate, 5 mM sodium pyrophos-
phate, 50 mM sodium fluoride, 1 mM 1,4-dithiothreitol and a protease
inhibitor cocktail (Roche Applied Science). The supernatants (10,000 g,
10 min) were stored at 80 C and protein concentration was determined
using the DC protein assay kit (Bio-Rad Laboratories) with BSA as standard.
mRNA levels. Cells were homogenized in 500ml TRIZOL+ after 1, 3
and 24 h of incubation with leucine and=or glutamine. Total RNA was
extracted according to the instructions provided by the manufacturer
(Invitrogen). RNA was quantified by spectrophotometry (260 nm) and its
concentration adjusted to 1mg= ml using RNase-free water.
2.2 SDS=PAGE and immunoblotting
Proteins were separated by SDS=PAGE and transferred to a PVDF (Poly-
vinylidene Difluoride) membrane for immunoblot analysis except for 4E-
BP1, which was transferred to a nitrocellulose membrane. Membranes
were then incubated in a 5% Blotto solution. The following phospho-
specific antibodies were added and incubated overnight at 4 C in Blotto
or in TBST (Tris-buffered saline with Tween-20) containing 1% BSA:
mTOR (Ser 2448, Ser 2481; Cell Signalling), p70S6k (Thr 389; Santa
Cruz), 4E-BP1 (Calbiochem), S6 (Ser235=236; Cell Signalling), eEF2
(Thr 56, provided by V. Stroobant from the Ludwig Institute, Brussels,
Belgium) and eIF2B (Ser 535, Biosource) (Some abbreviations are defined
in the legends to Figs. 4 and 6). Membranes were then incubated for 1 h at
room temperature in secondary antibody conjugated to horseradish perox-
idase (1:10000) in a 5% Blotto solution. Chemiluminescent detection was
carried out using an ECL Western blotting kit (Amersham Biosciences).
Then, the membranes were stripped and re-probed with a total antibody
(total mTOR, Cell Signalling; total p70S6k, Santa Cruz) to verify the
relative amount of the analyzed proteins through the experiment. The films
were scanned on an ImageScanner using the Labscan software (Amersham
Biosciences) and quantified with the Image Master 1D Image Analysis
Software (Amersham Biosciences). The results represent the phosphory-
lated form of the protein.
2.3 Protein kinase B activity
Protein kinase B (PKB) activity was measured by the phosphorylation of
a synthetic peptide after immunoprecipitation (100mg of protein extract)
with a total PKB antibody recognizing the PH-domain (Upstate Cell
Signalling) as previously described (Bertrand et al., 1999). To summarize,
the assay was performed in a final volume of 50ml in the presence
of 10mM MOPS (pH 7.0), 0.5 mM EDTA, 10 mM Mg-acetate, 0.1%
b-mercaptoethanol, 0.1 mM Mg-[g-32P] ATP (specific radioactivity
1000 cpm=pmol, Amersham Biosciences) and 0.25 mM substrate peptide
RPRAATF (Alessi et al., 1996). The reaction was continued for 20 min at
30 C. The supernatant was then spotted on to P81 phosphocellulose paper,
followed by washes in cold 75 mM phosphoric acid. 32P incorporation was
counted in a scintillation counter (LS 6500, Beckman) for 1 min.
2.4 Adenosine monophosphate-activated protein kinase activity
and acetyl-CoA carboxylase phosphorylation
Total adenosine monophosphate-activated protein kinase (AMPK) activity
was measured according to the method described by Marsin et al. (2000).
Acetyl-CoA carboxylase (ACC) phosphorylation, which is the best known
substrate of AMPK, was assessed by immunoblotting to confirm the re-
sults on the AMPK activity (anti-phospho specific Ser 79 ACC was a
generous gift from D. G. Hardie, Dundee, Scotland).
2.5 Incorporation of labelled [35S] methionine=cysteine
Cells were grown in serum-free DMEM for 1 h before the experiment.
Cells were then preincubated with 1 mM unlabelled methionine=cysteine
and with either 5 mM leucine or 5 mM glutamine, alone or in combination
for 15 min. After the preincubation period, 20ml of a protein labelling mix
(EasyTagTM Express Protein Labelling Mix, [35S] methionine=cysteine
mixture, NEN Life Science Products) were added to each plate. Cells
were lysed after 30 min, 3 h and 24 h, centrifuged and proteins were
precipitated with 10% trichloroacetic acid. The precipitated proteins were
dissolved in 0.1 N NaOH and precipitated again. The final pellet was
resuspended in 800ml of formic acid. 5 ml of scintillating liquid (Ultima-
gold, Perkin Elmer) was then added and 35S incorporation was counted in
a scintillation counter (LS 6500, Beckman) for 1 min.
2.6 Real time RT-PCR analyses
Reverse transcription (RT) was performed using the iScript synthesis kit
(Bio-Rad) on a MyIQ thermal cycler (Bio-Rad) with 1mg of total RNA in
a reaction volume of 20ml (4ml iScript reaction mix 5 , 1ml iScript
reverse transcriptase, 1ml RNA template, 14ml RNase-free water). Primers
were designed (Table 1) for mouse desmin, myogenin, caveolin 3 and
myosin heavy chain type II (MHC II) and b-actin. Quantitative real-time
polymerase chain reaction (PCR) was performed with the Sybr Green+
PCR Core kit or master mix (Eurogentec) on a MyIQ thermal cycler (Bio-
Rad) using the following cycle conditions: 10 min at 95 C, followed by 40
cycles of 1 min at 60 C and 15 sec at 95 C. For each gene, real time RT-
PCR was conducted in duplicate. The Ct values were calculated in every
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sample for each gene of interest as follows: Ctgene of interest – Ctreporter gene,
with b-actin as the reporter gene. Calculation of relative changes in the
expression level of one specific gene (Ct) was performed by subtrac-
tion ofCt from the control conditions to the correspondingCt from the
leucine and=or glutamine conditions. The mRNA results are presented as
2Ct.
2.7 Statistical analysis
The effect of leucine and glutamine was tested by unpaired Student’s t-
test. The significance threshold was set to P<0.05. The results are pre-
sented as the means  SEM.
3. Results
3.1 Opposite effects of leucine and glutamine
on the mTOR pathway
Incubation of C2C12 cells for 30 min in the differen-
tiation medium supplemented with 5 mM leucine in-
creased more than 10 fold the phosphorylation state
of p70S6k on Thr 389 (P<0.01, Fig. 1A) and almost
doubled the percentage of 4E-BP1 in the phosphorylat-
Table 1. Primer sequences
Forward Reverse
Desmin CAGGACCTGCTCAATGTGAA GCTGGTTTCTCGGAAGTTGA
Myogenin GTGCCCAGTGAATGCAACTC ACGATGGACGTAAGGGAGTG
Caveolin 3 GCTCGGATCATCAAGGACAT ACCTTCCATACACCGTCGAA
MHC II GAACCCTCCCAAGTACGACA GCATAACGCTCTTTGAGGTTG
b-actin TCCTGAGCGCAAGTACTCTGT CTGATCCACATCTGCTGGAAG
Sequences of primers (50–30) used for mRNA quantification by real-time RT-PCR. MHC II, myosin
heavy chain type II
Fig. 1. Effect of leucine, glutamine, alone or in combination, on the phosphorylation state of the mTOR pathway. Phosphorylation state of p70S6k (A),
4E-BP1 (B), mTOR (C and D), S6 (E) and eEF2 (F) after incubation with leucine (LEU) and=or glutamine (GLN) for 30 min. Results are expressed as
the means  SEM (n¼ 8 for p70S6k and 4E-BP1; n¼ 5 for mTOR, S6 and eEF2). P<0.05, P<0.01, P<0.001 vs. control
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ed ‘gamma’ form (P<0.001, Fig. 1B). This is in rela-
tion to the increase in the phosphorylation state of
mTOR on both Ser 2448 (P<0.01, Fig. 1C) and Ser
2481 (P<0.01, Fig. 1D). The leucine-induced p70S6k
activation resulted to the expected increase in phosphor-
ylation state of S6 on Ser 235=236 (þ70%, P<0.01,
Fig. 1E). By contrast, 5 mM glutamine decreased the
phosphorylation state of p70S6k by 80% (P<0.001,
Fig. 1A) and the percentage of 4E-BP1 in ‘gamma’
form by 40% (P<0.01, Fig. 1B). The inhibition in-
duced by glutamine was also observed on mTOR but
only on Ser 2448 (P<0.05, Fig. 1C) and not on Ser
2481 (Fig. 1D). The effects of leucine and glutamine on
the phosphorylation state of p70S6k were dose-depen-
dent. The more leucine was added to the medium, the
more p70S6k was phosphorylated reaching a maximum
at about 15–20 mM (Fig. 2A). Inversely, the more glu-
tamine, the larger inhibition on p70S6k was observed
(Fig. 2B).
When leucine and glutamine were combined, the effect
of leucine was predominant, overtaking the inhibition
exerted by glutamine. Indeed, after the addition of 5 mM
leucine and 5 mM glutamine, the phosphorylation state of
p70S6k was increased more than 10 fold (P<0.001,
Fig. 1A) and the percentage of the ‘gamma’ form of
4E-BP1 was nearly doubled (P<0.001, Fig. 1B). Similar
results were obtained on mTOR phosphorylation, on both
Ser 2448 (P¼ 0.06, Fig. 1C) and Ser 2481 (P<0.01,
Fig. 1D) and on S6 (P<0.05, Fig. 1E).
In contrast with the mTOR-mediated pathway, the
phosphorylation state of eEF2 on Thr 56 was unaffected
by either amino acid or the combination of both (Fig. 1F).
3.2 Effect of leucine and glutamine on proteins
regulating the mTOR pathway
Leucine and glutamine, alone or in combination, did not
affect the activity of PKB (Fig. 3A) and AMPK (Fig. 3B).
Fig. 2. Dose-response curves. Effect of in-
creasing doses of leucine (A, 0–20 mM) and
glutamine (B, 0–80 mM) on the phosphory-
lation state of p70S6k after 30 min
Fig. 3. Effect of leucine, glutamine, alone or in
combination, on proteins regulating the mTOR
pathway. PKB (A) and AMPK (B) activity.
Results are expressed as the means  SEM
(n¼ 9 for PKB; n¼ 6 for AMPK). (C) Effect
of rapamycin on the phosphorylation state of
p70S6k. Cells were preincubated with rapamy-
cin (100 nM) for 15 min before being incubated
for 30 min as indicated. LEU leucine; GLN
glutamine; RAPA rapamycin
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The absence of modification of AMPK activity was con-
firmed by an unchanged ACC phosphorylation state (Ser
79) (data not shown). To evaluate the implication of the
rapamycin-sensitive part of the mTOR pathway in the
response to leucine and glutamine, C2C12 cells were incu-
bated with 100 nM rapamycin (Fig. 3C). In all conditions,
Fig. 4. Specificity of glutamine. (A) Effect of
different amino acids on the phosphorylation
state of p70S6k for 30 min. CTRL control condi-
tions; ALA alanine; ARG arginine; ASN aspara-
gine; ASP aspartic acid; GLN glutamine; GLU
glutamic acid; GLY glycine; ILE isoleucine;
LEU leucine; MET methionine; NLE norleucine;
VAL valine; TAU taurine. Results are expressed
as the means  SEM (n¼ 3) and relative to the
control conditions represented by the dashed
line. (B, C) Effect of leucine (LEU), glutamine
(GLN), GlutaMAXTM (GAX), alone or in differ-
ent combinations, on the phosphorylation state
of p70S6k on Thr 389 (B) and on the percentage
of 4E-BP1 in gamma form (C) after an incuba-
tion period of 30 min. Results are expressed
as the means  SEM (n¼ 3). P<0.05,
P<0.01, P<0.001 vs. control
Fig. 5. Effect of leucine, glutamine, alone or in combination on the incorporation of labelled [35S] methionine=cysteine and the phosphorylation state
of p70S6k and eIF2B. The incorporation of labelled [35S] methionine=cysteine (n¼ 4) and the phosphorylation state of p70S6k on Thr 389 and eIF2B
on Ser 535 (n¼ 3) were quantified after 30 min, 1 h and 24 h of incubation with 5 mM leucine (A), 5 mM glutamine (B) and with both 5 mM leucine
(Leu) and 5 mM glutamine (Gln) (C). Results are expressed as the means  SEM and relative to the control conditions represented by the dashed line.
P<0.05, P<0.01, P<0.001 vs. control same time
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the p70S6k phosphorylation was totally abolished in the
presence of rapamycin, indicating that at least the action
of leucine is rapamycin-dependent.
3.3 Effect of other amino acids
C2C12 cells were also incubated with alanine, arginine,
asparagine, aspartic acid, glutamic acid, glycine, isoleu-
cine, methionine, norleucine, valine and taurine in order
to test if other amino acids could also modify the phos-
phorylation state of p70S6k (Fig. 4A). The concentration
used for each amino acid was 5 mM. None of them de-
creased the p70S6k phosphorylation state, whereas valine
(P<0.01), taurine (P<0.05) and norleucine (P<0.001),
but not isoleucine, were able to increase it (Fig. 4A). In
the same way, the effect of GlutaMAXTM (Life Technol-
ogies, Merelbeke, Belgium), a dipeptide composed of glu-
tamine and alanine which reduces glutamine degradation
into glutamic acid and ammonia, was studied. Like gluta-
mine, GlutaMAXTM strongly decreased the phosphoryla-
tion state of p70S6k (P<0.05, Fig. 4B) and 4E-BP1
(P<0.05, Fig. 4C).
3.4 Effect of leucine and glutamine on [35S] labelled
methionine=cysteine incorporation
Whereas the phosphorylation state of p70S6k is often used
as a marker of protein synthesis, Fig. 5 clearly shows that
the incorporation of [35S] labelled methionine=cysteine
did not follow the phosphorylation state of p70S6k in the
present study. The phosphorylation state of p70S6k was
increased by leucine alone (12 fold, P<0.01) and was
decreased by glutamine alone (80%, P<0.001) after
an incubation period of 30 min and it returned to basal
level after 3 and 24 h (Fig. 5A). In the presence of both
leucine and glutamine, p70S6k was more phosphorylated
than in control conditions at each time point studied (P<
0.05, Fig. 5C). In contrast to what happened with the
p70S6k phosphorylation state, the incorporation of [35S]
labelled methionine=cysteine was decreased by 25% af-
ter 30 min in cells incubated with 5 mM leucine alone
(P<0.05, Fig. 5A) and it was not altered by glutamine
alone or by the combination of leucine and glutamine.
3.5 Effect of leucine and glutamine on muscle-specific
mRNA levels
Since the mTOR pathway has also been shown to be
involved in myogenesis (Park et al., 2005) and in the
regulation of gene transcription by amino acid (Erbay T
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et al., 2003), we analyzed the effect of leucine and gluta-
mine on the expression of several muscle-specific genes.
The mRNA level for MHC II was decreased after 1 h by
leucine (60%) and glutamine (40%) alone as well as by
both amino acids together (50%) (P<0.05, Table 2).
After the same period of incubation, the combination of
leucine and glutamine also repressed the expression of
desmin mRNA (30%, P<0.05). After 3 h, the level of
desmin mRNA was increased by leucine and glutamine
alone (þ30%, P<0.05) and the level of myogenin mRNA
by leucine (þ50%, P<0.05). After 24 h, the mRNA level
for MHC II was increased by 3.7 fold when leucine and
glutamine were combined (P<0.05). Caveolin 3 mRNA
was not altered by leucine and=or glutamine.
4. Discussion
In this study, it is reported that leucine and glutamine have
opposite effects on the mTOR pathway in myogenic
C2C12 cells (Fig. 6). Like in other cell types (Fox et al.,
1998; Xu et al., 1998; Kimball et al., 1999; Krause et al.,
2002), leucine increased the phosphorylation state of
p70S6k and 4E-BP1 in our C2C12 cells. However, leucine
only transiently affected p70S6k since, after 3 h, the phos-
phorylation state of the latter returned to basal values
(Fig. 5). More strikingly, glutamine exerted an opposite
transient effect, reducing the phosphorylation state of
p70S6k and 4E-BP1, whereas this amino acid is known
to be a major activator of p70S6k in hepatocytes (Krause
et al., 2002). Therefore, the action of glutamine on the
phosphorylation state of p70S6k seems to be specific to the
cell type studied, glutamine being able to exert opposite
effects in two different cell types. Moreover, none of the
other amino acids tested decreased the phosphorylation
state of p70S6k, suggesting that glutamine has a specific
action in C2C12 cells (Fig. 4A). The dephosphorylation
induced by glutamine was probably not caused by its
transformation into glutamate in the medium. Even if
glutamate could have been transported into muscle cells
(Rennie et al., 1996), it did not alter the phosphorylation
state of p70S6k (Fig. 4A). Moreover, GlutaMAXTM, which
is a stabilized form of glutamine with the structure of a
dipeptide L-alanyl-L-glutamine, mimicked the effect of
glutamine by reducing the phosphorylation of p70S6k
and 4E-BP1 (Fig. 4B and C). These results strengthen
the hypothesis that glutamine itself rather than the pro-
ducts of its degradation, e.g. glutamic acid and ammonia,
is responsible for the inhibition observed on the mTOR-
mediated pathway.
Following these unexpected data, we tried to under-
stand further how leucine and glutamine exerted their
respective effect on mTOR and the physiological role of
this leucine- and glutamine-induced signalling. Several
proteins have been shown to regulate mTOR; PKB,
AMPK and raptor being of the highest importance
(Fig. 6). PKB is known to activate whereas AMPK is
known to inhibit (Kimura et al., 2003) the mTOR path-
way, respectively. However, neither leucine nor glutamine
was able to modify the activity of these kinases, demon-
strating that the signalling of both amino acids is indepen-
dent of PKB and AMPK (Fig. 3A and B). Leucine signal-
ling through mTOR is rapamycin-dependent as demon-
strated by the total inhibition of the action of this amino
acid by the addition of rapamycin (Fig. 3C). The binding
of rapamycin to its intracellular receptor, FK506-binding
protein, allows it to interact specifically with mTOR and
to prevent the binding of raptor to mTOR to form the
mTORC1 complex (Kim et al., 2002). Raptor is known
to mediate the activation of p70S6k by nutrients and the
increase in cell size. Our data confirm that raptor plays a
Fig. 6. Model for the control of the mTOR pathway, protein synthesis
and gene expression by leucine and glutamine in C2C12 cells. PKB
protein kinase B; mTOR mammalian target of rapamycin; raptor regu-
latory associated protein to mTOR; AMPK AMP-activated protein ki-
nase; p70S6k p70 ribosomal S6 kinase; 4E-BP1 eukaryotic initiation
factor 4E-binding protein 1; eEF2k eukaryotic elongation factor 2 ki-
nase; eEF2 eukaryotic elongation factor 2; S6 ribosomal protein S6;
mGCN2 mammalian general control non-derepressible kinase 2; eIF2a
eukaryotic initiation factor 2 alpha; eIF2b eukaryotic initiation factor
2B; GCN4 general control non-derepressible kinase 4. Bold lines effect
of leucine and=or glutamine; dashed lines no effect of leucine and=or
glutamine or untested
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key role in the action of leucine on the mTOR pathway in
C2C12 cells.
As p70S6k is generally believed to be a key regulator of
protein synthesis initiation, the present study investigated
whether the activation induced by leucine and the inhibi-
tion exerted by glutamine on the phosphorylation state of
p70S6k had any effect on the incorporation of labelled
methionine=cysteine. Unexpectedly, the incorporation of
labelled methionine=cysteine was only transiently affect-
ed by leucine and was not modified by glutamine (Fig. 5).
We observed a 25% decrease in labelled methionine=
cysteine incorporation induced by leucine after 30 min,
which is contrary to its effect on the mTOR=p70S6k path-
way. Our results on the phosphorylation of the ribosomal
S6 subunit and eEF2 might partially explain those on
labelled methionine=cysteine incorporation. Although
both lying downstream of p70S6k in the regulation of pro-
tein synthesis, S6 was only slightly affected and eEF2 not
modified at all by leucine and glutamine (Fig. 1E and F).
Since eIF2B has also been proposed as a key regulator of
protein synthesis (Kimball et al., 1998), its phosphoryla-
tion state after leucine and glutamine incubation was
analyzed (Fig. 5). But, in contrast to p70S6k, leucine and
glutamine did not affect its phosphorylation state, ruling
out its involvement in the decrease in labelled me-
thionine=cysteine incorporation induced by leucine after
30 min. Taken together, our data indicate that a change in
the phosphorylation state of p70S6k on Thr 389 does not
necessarily lead to a subsequent modification of the phos-
phorylation of its downstream targets and to a change in
amino acid incorporation. These data are noteworthy
since previous experiments showing modifications in pro-
tein metabolism were based on amino acid restriction
(Mordier et al., 2000) or were carried out during the pro-
liferation phase and high protein turnover (Kimball et al.,
1999; Du et al., 2007). By contrast, the present experi-
ments were carried out during the differentiation phase
characterized by a lower protein translation rate.
Since amino acid incorporation was only affected to a
minor extent by leucine, the study examined whether the
changes in p70S6k phosphorylation state could alter gene
expression (Fig. 6). Moreover, amino acids have recently
been shown to control IGF-II transcription and myogen-
esis through mTOR=p70S6k pathway (Erbay et al., 2003).
To characterize better the possible involvement of amino
acids in the regulation of gene expression and myogenesis
in C2C12 cells, we analyzed the mRNA level of muscle-
specific genes after incubation with leucine and=or glu-
tamine (Table 2). Although leucine and=or glutamine
modified the mRNA levels of desmin, myogenin and
MHC II, the changes did not follow the phosphorylation
state of the mTOR=p70S6k pathway, contrary to our hy-
pothesis, suggesting that the latter is probably not in-
volved in the control of the transcription of these genes.
Other pathways have been proposed to mediate the effect
of amino acids on gene expression. Although they were
not tested in this study, it seems likely that they do not
contribute to the present results. The hexosamine signal-
ling pathway, through glucosamine-6-phosphate and sub-
sequent O-linked glycosylation of various proteins, seems
to play an important role in regulating gene expression
(Marshall, 2006). Since glutamine is used as an amino
donor to convert fructose-6-phosphate to glucosamine-6-
phosphate (Marshall, 2006), it plays an important role in
the regulation of gene expression induced by the hexosa-
mine signalling pathway (Brasse-Lagnel et al., 2003).
However, this pathway essentially regulates the expres-
sion of genes encoding proteins that are involved in con-
trolling the insulin-stimulated glucose transport system
and triglyceride synthesis (Marshall, 2006). Amino acid
deprivation has also been shown to cause ER (endoplas-
mic reticulum) stress and to induce gene expression via
phosphorylation of eIF2a and eIF2B (Abcouwer et al.,
2002; Kilberg and Barbosa-Tessmann, 2002). However,
eIF2B was not affected by additional leucine and=or
glutamine (Fig. 5), ruling out a possible implication of
ER stress in the regulation of gene expression in the pres-
ent study.
In conclusion, leucine activates the mTOR pathway in
myogenic C2C12 cells. By contrast to leucine, glutamine
inhibits this pathway by dephosphorylating the Ser 2448
of mTOR and decreasing the phosphorylation state of
p70S6k and 4E-BP1. Whilst the phosphorylation state of
p70S6k is usually related to the rate of protein synthesis,
the incorporation of labelled methionine=cysteine remain-
ed unaffected by glutamine and was only transiently de-
creased by leucine. In line with the recent conception of
gene expression regulation by amino acids, leucine and
glutamine affected the mRNA levels of desmin, myogenin
and MHC II in a time-dependent manner but unrelated to
their effects on the mTOR=p70S6k pathway in C2C12 cells.
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